200 related articles for article (PubMed ID: 12324815)
1. Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities.
Bilbao JI; Quiroga J; Herrero JI; Benito A
Cardiovasc Intervent Radiol; 2002; 25(4):251-69. PubMed ID: 12324815
[TBL] [Abstract][Full Text] [Related]
2. Transjugular intrahepatic portosystemic shunts: an update.
Rosado B; Kamath PS
Liver Transpl; 2003 Mar; 9(3):207-17. PubMed ID: 12619016
[TBL] [Abstract][Full Text] [Related]
3. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunt.
Ochs A
Dig Dis; 2005; 23(1):56-64. PubMed ID: 15920326
[TBL] [Abstract][Full Text] [Related]
5. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt as a form of treatment for portal hypertension: indications and contraindications.
Brown RS; Lake JR
Adv Intern Med; 1997; 42():485-504. PubMed ID: 9048128
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt: present status, comparison with endoscopic therapy and shunt surgery, and future prospectives.
Rösch J; Keller FS
World J Surg; 2001 Mar; 25(3):337-45; discussion 345-6. PubMed ID: 11343189
[TBL] [Abstract][Full Text] [Related]
8. Stent graft in TIPS: technical and procedural aspects.
Fanelli F; Salvatori FM; Corona M; Bruni A; Pucci A; Boatta E; Dominelli V; Conchiglia A; Passariello R
Radiol Med; 2006 Aug; 111(5):709-23. PubMed ID: 16791461
[TBL] [Abstract][Full Text] [Related]
9. Recent position of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension.
Svoboda P; Kantorova I; Brhelova H; Vasickova J; Ochmann J
Hepatogastroenterology; 1997; 44(15):647-55. PubMed ID: 9222665
[TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
Haskal ZJ; Radhakrishnan J
J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN
Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
[TBL] [Abstract][Full Text] [Related]
12. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
[TBL] [Abstract][Full Text] [Related]
13. [Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome with extensive occlusion of the hepatic veins].
Wu XJ; Cao JM; Han JM; Li JS
Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1029-32. PubMed ID: 17074238
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial.
Sauer P; Hansmann J; Richter GM; Stremmel W; Stiehl A
Endoscopy; 2002 Sep; 34(9):690-7. PubMed ID: 12195325
[TBL] [Abstract][Full Text] [Related]
15. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines?
Riggio O; Ridola L; Lucidi C; Angeloni S
Dig Liver Dis; 2010 Jul; 42(7):462-7. PubMed ID: 20036625
[TBL] [Abstract][Full Text] [Related]
16. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients.
Rössle M; Siegerstetter V; Euringer W; Olschewski M; Kromeier J; Kurz K; Langer M
Acta Radiol; 2006 Sep; 47(7):660-6. PubMed ID: 16950701
[TBL] [Abstract][Full Text] [Related]
17. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
Nair S; Singh R; Yoselewitz M
J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
[TBL] [Abstract][Full Text] [Related]
18. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
[TBL] [Abstract][Full Text] [Related]
19. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt.
Khuroo MS; Al-Suhabani H; Al-Sebayel M; Al Ashgar H; Dahab S; Khan MQ; Khalaf HA
J Gastroenterol Hepatol; 2005 Oct; 20(10):1494-502. PubMed ID: 16174064
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting.
Wallace MJ; Madoff DC; Ahrar K; Warneke CL
Cancer; 2004 Jul; 101(2):337-45. PubMed ID: 15241832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
